We are live on
!
Find out more
Invesco Pharmaceuticals ETF
PJP
PJP
89 hedge funds and large institutions have $63.6M invested in Invesco Pharmaceuticals ETF in 2024 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 29 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.63% less ownership
Funds ownership: 23.76% → 23.13% (-0.63%)
4% less capital invested
Capital invested by funds: $66M → $63.6M (-$2.42M)
4% less funds holding
Funds holding: 93 → 89 (-4)
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
34% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 29
Holders
89
Holders Change
-4
Holders Change %
-4.3%
% of All Funds
1.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
19
Reduced
29
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$2.08M |
| 2 |
DBIA
Dumont & Blake Investment Advisors
Princeton,
New Jersey
|
+$1.58M |
| 3 |
Envestnet Asset Management
Chicago,
Illinois
|
+$886K |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$696K |
| 5 |
P
&Partners
Nashville,
Tennessee
|
+$297K |
